Find Clinical Trials

On this page, you will find different kinds of study results:

• A Lay summary which is a summary of clinical trial results written in an easy-to-understand way.
• A summary of results called synopsis which is written in scientific language. It is prepared for Medicines Agencies and Ethics Committees,
• A scientific publication which presents results for scientists and medical doctors.

208 Results

Protocol Code	Study Title	Active substance/Medical device	Study Phase	Therapeutic Area
CL3-LUSEO-001	Study assessing the glucose-lowering efficacy and safety of luseogliflozin on top of metformin in Caucasian…	Luseogliflozin	Phase 3	Metabolism
CL1-95032-005	Update in progress A Phase 1, Safety Lead-in and Randomized, Open-label, Perioperative Study of Vorasidenib in Combination With…	S095032	Phase 1	Cancers
AG120-C-005	A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled Study of AG-120 in Previously-treated Subjects with Nonresectable…	AG120, Ivosidenib	Phase 3	Cancers
CL3-05166-003	Evaluation of the clinical efficacy and safety of Amlodipine 5mg/ Bisoprolol fumarate 5mg /Perindopril arginine…	AMLODIPINE, Bisoprolol, PERINDOPRIL, S05166	Phase 3	Cardiovascular Diseases
CL3-05179-002	Evaluation of the clinical efficacy and safety of perindopril 10 mg/indapamide 2.5 mg/amlodipine 5 or…	AMLODIPINE BESILATE, BISOPROLOL FUMARATE, INDAPAMIDE, PERINDOPRIL ARGININE, S005179	Phase 3	Cardiovascular Diseases
CL3-95026-001	A randomised, open-label, multi-centre, two-arm Phase 3 study comparing futuximab/modotuximab in combination with trifluridine/tipiracil to…	Futuximab, Modotuximab, S095026	Phase 3	Cancers
CL1-95012-001	A study of PRS-344/S095012 (PD-L1x4-1BB bispecific antibody) in patients with solid tumors	Solid tumors	Phase 1-2	Cancers
CL1-95029-001	A Phase 1a/1b, Open-label, Multicenter Trial Investigating the Safety, Tolerability, and Preliminary Anti-neoplastic Activity of…	S095029	Phase 1	Cancers
AG120-881-C-001	A Phase 1, Multicenter, Randomized, Controlled, Open-label, Perioperative Study of AG-120 and AG-881 in Subjects…	AG-120, AG881	Phase 1	Cancers
AG270-C-001	A Phase 1 Study of AG-270 in the Treatment of Subjects With Advanced Solid Tumors…	AG-270	Phase 1	Cancers
AG120-C-009	A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of AG-120 in Combination with Azacitidine in…	AG-120, Ivosidenib	Phase 3	Cancers
AG120-C-002	A Phase 1, Multicenter, Open-Label, Dose-Escalation and Expansion, Safety, Pharmacokinetic, Pharmacodynamic, and Clinical Activity Study…	AG-120	Phase 1	Cancers
AG120-C-001	A Phase 1, Multicenter, Open-Label, Dose-Escalation and Expansion, Safety, Pharmacokinetic, Pharmacodynamic, and Clinical Activity Study…	AG-120	Phase 1	Cancers
AG120-221-C-001	A Phase 1, Multicenter, Open-Label, Safety Study of AG-120 or AG-221 in Combination With Induction…	AG-120, AG-221	Phase 1	Cancers
CL2-95014-002	A Multicentre, Phase II Randomized Study, Open-label, With 2-arm Parallel Group, Comparing the Pharmacokinetics of…	PEGASPARGASE, S095014	Phase 2	Cancers
CL2-95014-003	A Multicentre, Roll-over Study to Provide Continued Treatment With Lyophilized Pegaspargase (S95014) in Pediatric Patients…	PEGASPARGASE, S095014	Phase 2	Cancers
CL1-RTCMP-001	Target Involvement and Exploratory Biomarkers Investigations in Healthy Volunteers and in Patients With Type 2…		Phase 1	Metabolism
CL2-95015-001	A Multi-center, Open-label, Single-arm Phase 2/3 Trial Evaluating the Safety and Pharmacokinetics of Calaspargase Pegol…	Calaspargase pegol, S095015	Phase 2-3	Cancers
CL2-62798-010	A Multicentre, Randomized, Double-blind, Placebo-controlled Dose-finding Study of S62798 in Patients with Intermediate-High Risk Acute…	S062798	Phase 2	Cardiovascular Diseases
CL1-65487-003	Phase I / II, Open Label, Dose Escalation Part (Phase I) Followed by Noncomparative Expansion…	S065487	Phase 1-2	Cancers
CL3-95005-007	An open-label, randomised, phase III study comparing trifluridine/tipiracil in combination with bevacizumab to trifluridine/tipiracil monotherapy…	TIPIRACIL, TRIFLURIDINE, S095005	Phase 3	Cancers
CL1-64315-004	Phase I/II, international, multicentre, open-label, non-randomised, non-comparative, study evaluating the safety, tolerability and clinical activity…	S064315	Phase 1-2	Cancers
CL2-95011-001	A phase IIa efficacy and safety trial with intravenous S95011 in primary Sjögren’s Syndrome patients.…	S095011	Phase 2	Immune-Inflammatory Diseases
CL3-05167-005	Efficacy and safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in adult patients with arterial…	ATORVASTATIN, PERINDOPRIL, S005167	Phase 3	Cardiovascular Diseases
CL1-95014-001	A Phase 2 Clinical Study of Pegaspargase in Patients With Newly Diagnosed, Untreated Acute Lymphoblastic…	PEGASPARGASE, S095014	Phase 2	Cancers

1 2 … 8 9 Next